Elevated Expression and Pro-Inflammatory Activity of IL-36 in Patients with Systemic Lupus Erythematosus

CD24hiCD27+ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease

(2015) A. de Masson et al.   BLOOD

Interleukin-36α axis is modulated in patients with primary Sjögren's syndrome

(2015) F. Ciccia et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

IL-36 Promotes Myeloid Cell Infiltration, Activation, and Inflammatory Activity in Skin

(2014) A. M. Foster et al.   JOURNAL OF IMMUNOLOGY

IL-36 has proinflammatory effects in skin but not in joints

(2014) Damien Dietrich et al.   Nature Reviews Rheumatology

Biology of IL-36 cytokines and their role in disease

(2013) Mark S. Gresnigt et al.   SEMINARS IN IMMUNOLOGY

Serum levels of cytokines in systemic lupus erythematosus

(2013) M. Zhang et al.   ZEITSCHRIFT FUR RHEUMATOLOGIE

The severity of experimental arthritis is independent of IL-36 receptor signaling

(2013) Céline Lamacchia et al.   ARTHRITIS RESEARCH & THERAPY

IL-10-producing regulatory B cells (B10 cells) in autoimmune disease

(2013) Ioannis Kalampokis et al.   ARTHRITIS RESEARCH & THERAPY

The novel cytokine interleukin-36α is expressed in psoriatic and rheumatoid arthritis synovium

(2012) Silke Frey et al.   ANNALS OF THE RHEUMATIC DISEASES

IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells

(2012) S. Vigne et al.   BLOOD

IL-36 in psoriasis

(2012) JE Towne et al.   CURRENT OPINION IN PHARMACOLOGY

Psoriasiform dermatitis is driven by IL-36–mediated DC-keratinocyte crosstalk

(2012) Luigi Tortola et al.   JOURNAL OF CLINICAL INVESTIGATION

Interleukin-36 cytokines enhance the production of host defense peptides psoriasin and LL-37 by human keratinocytes through activation of MAPKs and NF-κB

(2012) Toan The Nguyen et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Decrease in Proportion of CD19+CD24hiCD27+ B Cells and Impairment of Their Suppressive Function in Graves’ Disease

(2012) Bingbing Zha et al.   PLoS One

IL-36R ligands are potent regulators of dendritic and T cells

(2011) S. Vigne et al.   BLOOD

Interleukin-36 (IL-36) Ligands Require Processing for Full Agonist (IL-36α, IL-36β, and IL-36γ) or Antagonist (IL-36Ra) Activity

(2011) Jennifer E. Towne et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

IL-1F5, -F6, -F8, and -F9: A Novel IL-1 Family Signaling System That Is Active in Psoriasis and Promotes Keratinocyte Antimicrobial Peptide Expression

(2011) A. Johnston et al.   JOURNAL OF IMMUNOLOGY

Inter-Regulation of Th17 Cytokines and the IL-36 Cytokines In Vitro and In Vivo: Implications in Psoriasis Pathogenesis

(2011) Yijun Carrier et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients

(2010) Paul A. Blair et al.   IMMUNITY

IL-1RL2 and Its Ligands Contribute to the Cytokine Network in Psoriasis

(2010) H. Blumberg et al.   JOURNAL OF IMMUNOLOGY

Regulatory B cells in autoimmunity: developments and controversies

(2010) Claudia Mauri et al.   Nature Reviews Rheumatology

Cytokines as therapeutic targets in SLE

(2010) Lars Rönnblom et al.   Nature Reviews Rheumatology

Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: Implications for Th17-mediated inflammation in auto-immunity

(2008) Chun Kwok Wong et al.   CLINICAL IMMUNOLOGY